Official EU label nameGlossary entry 4858

CAFFEINE BENZOATE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:5743-17-9

EC:227-257-3

Ingredient index records:

CAFFEINE BENZOATE

Cosmetic functions: SKIN CONDITIONING

Benzoic acid, compd. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione (1:1)

Open full local profile

1 matched or reported name

CAFFEINE BENZOATE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name CAFFEINE BENZOATE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 5743-17-9

CAS 5743-17-9PubChem CID 64120

Caffeine benzoate

IUPAC name: benzoic acid;1,3,7-trimethylpurine-2,6-dione

Molecular formula: C15H16N4O4
Molecular weight: 316.31 g/mol
Exact mass: 316.11715500 Da
Topological polar surface area: 95.7 Å²
Hydrogen-bond donors: 1
Hydrogen-bond acceptors: 5
Covalent units: 2
Defined stereocentres: 0

Also known as

caffeine, sodium benzoate drug combinationC2154V12SERefChem:122663227-257-3Caffeine-sodium benzoate1,3,7-Trimethyl-1H-purine-2,6(3H,7H)-dione benzoate1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; benzoic acidcaffeine - sodium benzoate

8 more reported names

Caffeine, monobenzoateEINECS 227-257-3UNII-C2154V12SEVXXKVQICUHMECR-UHFFFAOYSA-NCaffeine, benzoate drug combination1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, monobenzoateBenzoic acid--1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione (1/1)1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-1,3,7-TRIMETHYL-, BENZOATE (1:1)

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

EPA DTXSID:DTXSID10206016
PubMed:18179623
PubMed:16919674
PubMed:7834261
PubMed:5561865
PubMed:1540370

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision